SINGAPORE, Oct 27 (Bernama-GLOBE NEWSWIRE) — Claritas HealthTech Pte. Ltd. (“Claritas”), a healthcare technology company specializing in AI-assisted diagnosis and image enhancement to improve the quality and efficiency of medical imaging, announces today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market iRAD™. Claritas iRAD™ is an image processing software that enhances MRI, CT, and X-Ray images through noise reduction and improvement in contrast and entropy.
Claritas has developed iRAD™, an advanced proprietary image enhancement product that produces a significantly enhanced image while ensuring there is no alteration or degradation to the image. iRAD™ integrates easily into radiologists’ existing PACS becoming part of the clinicians’ workflow, where enhanced images can be compared with the original image. The image enhancement can be done locally on site (if required by the institution) or on the cloud, providing ease of access. The product provides physicians with adjustable controls to calibrate the degree of enhancement of each parameter.
